GeminIQ Website Logo

Viewing AMPH free

Subscribe for full history, 90+ metrics, screener, watchlist...

Amphastar Pharmaceuticals, Inc.

AMPH

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
224171170216188183152192190201144267
Restricted Cash Current
000000000004
Short Term Investments
671211136044547058288811333
Restricted Investments Current
222222222222
Accounts Receivable Net Current
145148144147133145136140131138115119
Inventory Net
180170177186192185154130122115106110
Prepaid Expense And Other Assets Current
11121326201818188996
Assets Current
631634636639581588534546483555490543
Property Plant And Equipment Net
316307311309310308297295288289283281
Finance Lease Right Of Use Asset
-00000000111
Operating Lease Right Of Use Asset
737143454446473232313233
Intangible Assets Net Including Goodwill
648560566572578585591595601607613619
Long Term Investments
----2611-1015151
Other Assets Noncurrent
333331302823262424232625
Deferred Income Tax Assets Net
424242717171715353535341
Assets
1,7441,6481,6291,6661,6151,6261,5771,5451,4921,5741,5131,545
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current
25115314819116717615715313111793223
Accrued Income Taxes Current
100611510126231
Long Term Debt And Capital Lease Obligations Curre…
222110000000
Operating Lease Liability Current
9108888744444
Liabilities Current
263164158205176199174159137255225258
Accrued Income Taxes Noncurrent
666777766667
Long Term Debt And Capital Lease Obligations
610610609609608604602596587594590638
Operating Lease Liability Noncurrent
676538393941422929293030
Deferred Income Tax Liabilities Net
-----------0
Other Liabilities Noncurrent
292930292824212719182316
Liabilities
976875840889858875845818778902873949
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital
553544535527521509505496488476486478
Retained Earnings Accumulated Deficit
704673667642625594569531490452409373
Accumulated Other Comprehensive Income Loss Net Of…
-6-6-5-5-5-8-9-9-9-9-8-8
Treasury Stock Value
-483-438-408-388-383-344-333-291-256-247-247-247
Stockholders Equity
768773789777757751732728713672639595
Liabilities And Stockholders Equity
1,7441,6481,6291,6661,6151,6261,5771,5451,4921,5741,5131,545
Preferred Stock Par Or Stated Value Per Share
000000000000
Preferred Stock Shares Authorized
202020202020202020202020
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
300300300300300300300300300300300300
Common Stock Shares Issued
626262626261616160605959
Shares Outstanding
434546464648484849494848

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-21.56%-9.36%-22.10%---------
20254.30%-6.37%-9.25%41.63%24.19%13.41%14.32%11.93%6.97%-26.39%-13.63%-36.32%
20240.28%-5.24%0.64%13.75%12.07%17.36%-1.95%-17.99%-20.81%3.31%-12.10%-11.08%
2023----12.35%-26.07%-28.24%27.52%36.17%18.63%-6.16%-14.09%-6.64%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.40
3.85
4.02
3.12
3.29
2.95
3.07
3.43
3.52
2.18
2.17
2.10
Quick Ratio
1.67
2.75
2.82
2.08
2.09
1.93
2.08
2.50
2.57
1.69
1.66
1.65
Working Capital
367.75M
469.21M
477.86M
434.24M
404.42M
388.91M
360.31M
386.94M
345.67M
299.91M
264.19M
285.04M
Leverage & Debt
Debt to Equity
1.27
1.13
1.07
1.15
1.13
1.16
1.15
1.12
1.09
1.34
1.37
1.60
Interest Coverage TTM
4.37
4.53
5.51
5.93
7.07
6.95
6.77
6.42
5.69
5.98
7.25
9.92
Debt Ratio
0.56
0.53
0.52
0.53
0.53
0.54
0.54
0.53
0.52
0.57
0.58
0.61
Efficiency & Turnover
Asset Turnover TTM
0.43
0.44
0.45
0.45
0.47
0.46
0.47
0.47
0.50
0.58
0.57
0.53
Days Sales Outstanding TTM
69.46
74.08
70.95
72.27
66.77
70.62
62.64
65.23
60.45
64.44
57.70
59.51
Receivables Turnover TTM
5.25
4.93
5.14
5.05
5.47
5.17
5.83
5.60
6.04
5.66
6.33
6.13
Per Share Metrics
Diluted EPS TTM
1.78
1.71
2.03
2.34
4.48
4.46
4.62
4.61
3.20
2.92
2.60
2.51
Free Cash Flow Per Share TTM
3.50
2.98
2.59
2.44
2.39
3.15
3.56
3.50
3.64
3.34
3.01
2.87
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
47.68%
47.34%
49.46%
49.36%
49.86%
50.50%
51.08%
52.98%
54.68%
54.33%
54.49%
54.24%
Operating Profit Margin TTM
15.66%
16.20%
19.50%
20.73%
25.14%
26.65%
28.06%
29.61%
32.25%
31.29%
30.57%
30.07%
Net Profit Margin TTM
10.76%
11.00%
13.63%
15.43%
29.87%
30.49%
32.88%
33.01%
23.36%
22.88%
21.34%
22.50%
Growth Metrics
Net Revenue Growth (1Y)
1.02%
-1.39%
-1.65%
-0.03%
1.37%
8.05%
13.59%
20.33%
31.80%
30.38%
29.14%
24.02%
Net Income Growth (1Y)
-63.61%
-64.43%
-59.24%
-53.26%
29.62%
44.00%
74.96%
76.54%
63.34%
66.04%
50.51%
80.47%
EPS Growth (1Y)
-60.85%
-62.61%
-57.77%
-51.10%
35.02%
45.73%
74.36%
76.83%
61.66%
65.31%
51.40%
81.22%
Valuation Metrics
P/E TTM
11.21
11.21
12.76
11.10
4.99
6.20
7.47
9.88
11.75
13.69
21.70
16.56
P/B TTM
1.15
1.15
1.59
1.59
1.42
1.84
2.46
3.24
2.74
3.15
4.67
3.76
P/S TTM
1.21
1.23
1.74
1.71
1.49
1.89
2.46
3.26
2.74
3.13
4.63
3.72
Market Cap
880.74M
887.86M
1.25B
1.24B
1.08B
1.38B
1.80B
2.36B
1.96B
2.12B
2.99B
2.24B
Enterprise Value
1.27B
1.33B
1.69B
1.63B
1.50B
1.80B
2.25B
2.76B
2.35B
2.51B
3.43B
2.61B
Calculated Values
Free Cash Flow TTM
152.89M
135.19M
121.23M
113.26M
112.19M
150.23M
172.35M
170.15M
178.13M
160.93M
145.34M
139.83M
Net Debt
388.20M
440.30M
439.98M
393.01M
420.73M
421.07M
450.02M
404.35M
397.25M
393.05M
445.48M
367.60M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-12-17Sale
Owner: Zhou, Rong
Title: SENIOR EVP, PRODUCTION CENTER
Shares: 9,787
Price/Share: $26.20
Value: $256,419.40
Shares Owned: 138,043
Relationship: Officer
Ownership: Direct
2025-12-12Sale
Owner: Petersen, Floyd F.
Title: -
Shares: 2,426
Price/Share: $25.92
Value: $62,881.92
Shares Owned: 71,368
Relationship: Director
Ownership: Direct
2025-11-25Sale
Owner: Prins, Richard K
Title: -
Shares: 4,179
Price/Share: $27.10
Value: $113,250.90
Shares Owned: 35,183
Relationship: Director
Ownership: Direct
2025-11-13Sale
Owner: Petersen, Floyd F.
Title: -
Shares: 16,679
Price/Share: $26.49
Value: $441,826.71
Shares Owned: 75,531
Relationship: Director
Ownership: Direct
2025-11-03Sale
Owner: Petersen, Floyd F.
Title: -
Shares: 500
Price/Share: $25.27
Value: $12,635.00
Shares Owned: 75,531
Relationship: Director
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
68.04%
Inst. Shares: 30,836,074
Shares Outstanding: 45,322,000
2025-12-31
69.86%
Inst. Shares: 32,654,452
Shares Outstanding: 46,743,000
2025-09-30
67.95%
Inst. Shares: 31,577,972
Shares Outstanding: 46,474,000
2025-06-30
67.05%
Inst. Shares: 31,481,321
Shares Outstanding: 46,949,000
2025-03-31
66.65%
Inst. Shares: 31,750,732
Shares Outstanding: 47,641,000

Amphastar Pharmaceuticals, Inc. (AMPH) — SEC Financial Statements & Analysis

Amphastar Pharmaceuticals, Inc. (AMPH) is a pharmaceutical preparations company. Amphastar Pharmaceuticals, Inc. trades on Nasdaq as: AMPH. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Amphastar Pharmaceuticals, Inc. reported a 1.02% year-over-year revenue growth, a Gross Profit Margin of 47.68% (TTM), a Debt-to-Equity ratio of 1.27x, a Price-to-Sales (P/S) ratio of 1.21x (TTM), a Price-to-Book (P/B) ratio of 1.15x (TTM), at a market cap of $880.74M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
1.02%
Gross Profit Margin TTM
47.68%
Debt To Equity
1.27x
P/S TTM
1.21x
P/B TTM
1.15x
Market Cap
$880.74M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Amphastar Pharmaceuticals, Inc. in?

Amphastar Pharmaceuticals, Inc. (AMPH) operates in the Pharmaceutical Preparations industry.

What is AMPH's market cap?

Amphastar Pharmaceuticals, Inc. (AMPH) has a market capitalization of $880.74M as of 2026-06-30.

What is AMPH's P/E ratio?

Amphastar Pharmaceuticals, Inc. (AMPH)'s trailing twelve month P/E ratio is 11.21x as of 2026-06-30.

What exchange does AMPH trade on?

Amphastar Pharmaceuticals, Inc. (AMPH) trades on the Nasdaq.

Wall Street's data.
Main Street's price.